HIE disclosure with purpose-of-use check
Outbound ADT/CCD fires only when treating relationship and consent attributes validate; otherwise the interface holds the message for review.
AC-3(9) Controlled Release
High Risk
Complex
Medium Cost
AC-3(9) requires releasing information outside the system only when the system validates that the information is authorized for release and the destination is authorized to receive it (organization-defined validation rules). Healthcare releases include HIE queries, payer attachments, patient portal downloads, research extracts, and print/fax. Controlled release stops 'any logged-in user can send anything anywhere.'
Control Objective
Ensure ePHI and related sensitive information leave systems only after policy checks confirm the release is authorized and the recipient/destination is approved.
Implementation Guidance
- Map outbound channels: HIE, Direct, clearinghouse, portal, email gateway, print/fax, API partners, removable media.
- Define validation rules per channel (purpose of use, consent, minimum necessary, BA status, destination allowlist).
- Block or quarantine releases that fail validation (wrong recipient domain, missing auth, bulk thresholds).
- Prefer structured interfaces over ad-hoc email of charts.
- Log release decisions (allow/deny) with user, patient/context, and destination.
- Apply DLP rules for unstructured ePHI in mail and cloud sync.
- Require dual authorization for novel or high-volume releases (AC-3(2)).
- Review denied and allowed high-volume releases weekly with privacy.
Real-World Use Cases
How this control shows up in healthcare and HIPAA-covered environments.
Patient portal record download
Portal releases CCD to the authenticated patient identity only — not to an arbitrary email typed into a form without identity proofing.
Analyst tries to email identifiable spreadsheet
DLP/controlled-release rules quarantine the message; privacy reviews and either approves a limited dataset path or denies.
Best Practices
- Inventory every egress path for ePHI.
- Allowlist high-risk destinations where feasible.
- Threshold alerts on bulk release.
- Prefer automated interfaces with validation over manual sends.
- Retain release decision logs.
- Train staff on approved release channels.
Common Gaps & Violations
- Unrestricted forwarding of EHR mail with attachments.
- Faxing to numbers not verified.
- Research extracts emailed without DUA checks.
- No logging of who released what to HIEs.
- USB copy of schedules with full demographics allowed.
Required Documentation
- Controlled release / disclosure technical standard
- Egress channel inventory
- Validation rules by channel
- DLP / interface allowlist configs
- Sample release decision logs and reviews
How to Test & Validate
- Attempt unauthorized destination release; confirm block/quarantine.
- Complete an authorized interface release; confirm validation and log.
- Test bulk-threshold alert with a synthetic extract.
- Verify portal releases bind to the correct patient identity.
- Sample fax/email releases for verification evidence.
Audit Considerations
Privacy Rule disclosure accounting and Security Rule access control meet at egress. Assessors ask how you prevent unauthorized outbound ePHI — controlled release is the technical answer.
HIPAA Mapping
How this NIST control supports HIPAA Security Rule expectations.
- 164.502 Uses and disclosures — only permitted/required disclosures; technical release controls support this.
- 164.514 Minimum Necessary — validate amount released.
- 164.312(a)(1) Access Control — control who can cause release actions.
- 164.312(e) Transmission Security — protect ePHI when release uses electronic transmission.
Compliance Tips
- Make 'approved channel' the default answer in HIM training.
- Put bulk-release thresholds in writing (e.g., >500 patients needs privacy co-approval).
- Align AC-3(9) with BA inventory so destinations without BAAs fail validation.
Frequently Asked Questions
Does controlled release apply to treatment disclosures?
Yes — even TPO disclosures should use authorized systems and validated recipients (correct provider directory entry, etc.).
Is DLP alone enough?
DLP helps for unstructured channels; interfaces need explicit authorization/destination checks too.
What about patient right of access?
Release to the patient is authorized but still needs identity validation and secure delivery channels.
References & Resources
- NIST SP 800-53 Rev. 5 — AC-3(9)
- Related: AC-3, AC-4, AC-21, AU-2, SI-12, SC-8
Related Guidelines
Related controls that commonly accompany AC-3(9).
Need Help Implementing AC-3(9)?
Our auditors map NIST SP 800-53 controls to your HIPAA Security Rule program — policies, technical evidence, and audit readiness.